Serum levels of three angiogenic factors in systemic lupus erythematosus and their clinical significance

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Zhou, Ling ^a   Lu, Guoyuan ^a   Shen, Lei ^a   Wang, Linfeng ^a   Wang, Mingjun ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; COMPLEMENT COMPONENT C3; CREATININE; FIBROBLAST GROWTH FACTOR 2; GLUCOSE; HEMOGLOBIN; PLACENTAL GROWTH FACTOR; SERUM ALBUMIN; TRIACYLGLYCEROL; URIC ACID; VASCULOTROPIN; ANGIOGENIC PROTEIN; PLACENTA PROTEIN; VASCULOTROPIN A;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD CELL COUNT; BLOOD SAMPLING; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ACTIVITY SCORE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; YOUNG ADULT; BLOOD; MIDDLE AGED;

ADULT; ANGIOGENIC PROTEINS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREGNANCY PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84893365237     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/627126     Document Type: Article

References (23)

1. Cieślik P., Hrycek A., Kłuciński P., Vasculopathy and vasculitis in systemic lupus erythematosus. Polskie Archiwum Medycyny Wewne 2008 118 1-2 57 63 (Pubitemid 351316529)
2. López-Mejías R., Corrales A., Genre F., Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis. Clinical and Experimental Rheumatology 2013 31 5 761 766
3. Genre F., Miranda-Filloy J. A., López-Mejias R., Antitumour necrosis factor-a therapy modulates angiopoietin-2 serum levels in non-diabetic ankylosing spondylitis patients. Annals of the Rheumatic Diseases 2013 72 7 1265 1267
4. Maruotti N., Cantatore F. P., Nico B., Vacca A., Ribatti D., Angiogenesis in vasculitides. Clinical and Experimental Rheumatology 2008 26 3 476 483 2-s2.0-48949117166 (Pubitemid 352003221)
5. Rueda B., Lopez-Nevot M. A., Lopez-Diaz M. J., Garcia-Porrua C., Martín J., Gonzalez-Gay M. A., A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. Journal of Rheumatology 2005 32 9 1737 1741 2-s2.0-24944519879 (Pubitemid 41324813)
6. Rodríguez-Rodríguez L., García-Bermúdez M., González-Juanatey C., Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients. Tissue Antigens 2011 77 4 291 297
7. Navarro C., Candia-Zúñiga L., Silveira L. H., Ruiz V., Gaxiola M., Avila M. C., Amigo M. C., Vascular endothelial growth factor plasma levels in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Lupus 2002 11 1 21 24 2-s2.0-0036179906 10.1191/0961203302lu131oa (Pubitemid 34178115)
8. Szekanecz Z., Koch A. E., Vascular involvement in rheumatic diseases: 'Vascular rheumatology'. Arthritis Research and Therapy 2008 10 5, article 224 2-s2.0-54249095828 10.1186/ar2515
9. D'Cruz D., Vasculitis in systemic lupus erythematosus. Lupus 1998 7 4 270 274 2-s2.0-0031800194 10.1191/096120398678920082 (Pubitemid 28264005)
10. Heshmat N. M., El-Kerdany T. H., Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus. Pediatric Allergy and Immunology 2007 18 4 346 353 2-s2.0-34250716422 10.1111/j.1399-3038.2006.00510.x (Pubitemid 46961746)
11. Robak E., Wóniacka A., Sysa-Jdrzejowska A., Stpień H., Robak T., Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity. European Cytokine Network 2001 12 3 445 452 2-s2.0-0034813356 (Pubitemid 32905263)
12. Maruotti N., Annese T., Cantatore F. P., Ribatti D., Macrophages and angiogenesis in rheumatic diseases. Vascular Cell 2013 5 1 11
13. Robak E., Sysa-Jdrzejewska A., Robak T., Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus. Mediators of Inflammation 2003 12 5 293 298 2-s2.0-0242441067 10.1080/09629350310001619726 (Pubitemid 37392901)
14. Carmeliet P., Moons L., Luttun A., Vincenti V., Compernolle V., De Mol M., Wu Y., Bono F., Devy L., Beck H., Scholz D., Acker T., Dipalma T., Dewerchin M., Noel A., Stalmans I., Barra A., Blacher S., Vandendriessche T., Ponten A., Eriksson U., Plate K. H., Foidart J.-M., Schaper W., Charnock-Jones D. S., Hicklin D. J., Herbert J.-M., Collen D., Persico M. G., Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nature Medicine 2001 7 5 575 583 2-s2.0-19244379078 10.1038/87904 (Pubitemid 32448325)
15. Bottomley M. J., Webb N. J. A., Watson C. J., Holt L., Bukhari M., Denton J., Freemont A. J., Brenchley P. E. C., Placenta growth factor (PIGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid. Clinical and Experimental Immunology 2000 119 1 182 188 2-s2.0-0033956368 10.1046/j.1365-2249.2000.01097.x (Pubitemid 30064608)
16. Sbaa E., DeWever J., Martinive P., Bouzin C., Frérart F., Balligand J.-L., Dessy C., Feron O., Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis. Circulation Research 2006 98 9 1219 1227 2-s2.0-33745019167 10.1161/01.RES.0000220648.80170.8b (Pubitemid 43948109)
17. Oura H., Bertoncini J., Velasco P., Brown L. F., Carmeliet P., Detmar M., A critical role of placental growth factor in the induction of inflammation and edema formation. Blood 2003 101 2 560 567 2-s2.0-0037438583 10.1182/blood-2002-05-1516 (Pubitemid 36077578)
18. Robak E., Kulczycka L., Sysa-Jdrzejowska A., Wierzbowska A., Robak T., Circulating proangiogenic molecules PIGF, SDF-1 and sVCAM-1 in patients with systemic lupus erythematosus. European Cytokine Network 2007 18 4 181 187 2-s2.0-37849011234 10.1684/ecn.2007.0103
19. Seghezzi G., Patel S., Ren C. J., Gualandris A., Pintucci G., Robbins E. S., Shapiro R. L., Galloway A. C., Rifkin D. B., Mignatti P., Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. Journal of Cell Biology 1998 141 7 1659 1673 2-s2.0-0041440927 10.1083/jcb.141.7.1659 (Pubitemid 28309179)
20. Hrycek A., Janowska J., Cieślik P., Selected angiogenic cytokines in systemic lupus erythematosus patients. Autoimmunity 2009 42 5 459 466 2-s2.0-70349865059 10.1080/08916930902960339
21. Frieri M., Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches. Current Allergy and Asthma Reports 2012 12 1 25 32 2-s2.0-84857633905 10.1007/s11882-011-0236-1
22. Maruotti N., Cantatore F. P., Ribatti D., Thalidomide in treatment of connective diseases and vasculities. Reumatismo 2006 58 3 187 190 (Pubitemid 44450244)
23. Walchner M., Meurer M., Plewig G., Messer G., Clinical and immunologic parameters during thalidomide treatment of lupus erythematosus. International Journal of Dermatology 2000 39 5 383 388 (Pubitemid 30335791)